Adenosine deaminase inhibition.

Area of Science:

• Biochemistry
• Immunology
• Pharmacology

Background:

• Adenosine deaminase (ADA) regulates purine metabolism and adenosine levels.
• Adenosine signaling influences physiological functions and inflammation.
• Elevated ADA activity is linked to various diseases.

Purpose of the Study:

• To review data on increased ADA activity in diseases.
• To discuss the impact of ADA inhibition across different conditions.
• To assess the current state of ADA inhibitor development and clinical application.

Main Methods:

• Literature review of studies on adenosine deaminase.
• Analysis of in vitro and in vivo research on ADA activity and inhibition.
• Compilation of data on the clinical course of diseases with altered ADA activity.

Main Results:

• Adenosine deaminase activity increases in several diseases.
• ADA inhibition shows significant effects on disease progression in various cases.
• Many inhibitors have been developed, but clinical applications are limited.

Conclusions:

• Adenosine deaminase plays a dual role in inflammation.
• ADA inhibitors have therapeutic potential but face limited clinical use.
• Further in vivo studies are crucial for expanding clinical applications of ADA inhibitors.